Coagulin-B: Removed Phase I study

Avigen Inc. (AVGN), Alameda, Calif. Product: Coagulin-B Business: Gene/Cell therapy Therapeutic category: Gene therapy, Thrombolysis/Thrombosis Target: Clotting factors Description: Adeno-associated v...